Internal Server Error

InDevR - About the company

InDevR is an acquired company based in Boulder (United States), founded in 2003 by Kathy Rowlen, John Birks and Laura Kuck. It operates as a Manufacturer of biotherapeutics, vaccines and diagnostic products. InDevR has raised $16M in funding from Adjuvant Capital and BioMerieux. The company has 75 active competitors, including 17 funded and 15 that have exited. Its top competitors include companies like PathogenDX, Agendia and Inflammatix.

Company Details

Manufacturer of biotherapeutics, vaccines and diagnostic products. The company provides progressive analytical technologies that enhance and accelerate vaccine characterization and production. It also develops next-generation diagnostic products that will enable unprecedented tracking of seasonal and emerging influenza viruses around the globe. It offers a range of other microarray-related products. It provides the Cypher One product for automated hemagglutination analysis and the VaxArray™ Influenza potency assay for rapid quantification of hemagglutinin protein and many R&D tools.
Social
XFacebook
Email ID
*****@indevr.com
Phone Number
+1 **********
Key Metrics
Founded Year
2003
Location
Boulder, United States
Stage
Acquired
Total Funding
$16M in 15 rounds
Latest Funding Round
Ranked
Employee Count
25 as on Sep 30, 2026
Similar Companies
Exit Details
Acquired

InDevR's acquisition details

InDevR got acquired on Feb 06, 2026.
Click here to take a look at InDevR's acquisition in detail
Sign up to download InDevR's company profile

InDevR's funding and investors

InDevR has raised a total funding of $16M over 15 rounds. Its first funding round was on Nov 01, 2005. Its latest funding round was a Series B round on Jan 17, 2023 for $*****. 2 investors participated in its latest round. InDevR has 4 institutional investors.

Here is the list of recent funding rounds of InDevR:lockFilter this list
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Jan 17, 2023
4369252
Series B
4498905
7804738
4577569
7447610
Aug 29, 2019
6360887
Series A
4888881
6482962
5354323
5156480
Jul 21, 2014
4724009
Grant (prize money)
3983710
8227272
7249932
lockAccess funding benchmarks and valuations. Sign up today!

InDevR's founders and board of directors

Founder? Claim Profile
The founders of InDevR are Kathy Rowlen, John Birks and Laura Kuck.
Here are the details of InDevR's key team members:

InDevR's employee count trend

InDevR has 25 employees as of Sep 26. Here is InDevR's employee count trend over the years:
Employee count trend for InDevR
lockUncover InDevR's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

InDevR's Competitors and alternates

Top competitors of InDevR include PathogenDX, Agendia and Inflammatix. Here is the list of Top 10 competitors of InDevR, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for PathogenDX
PathogenDX
2014, Tucson (United States), Series B
Provider of DNA-based pathogen testing kits
$11.6M
62/100
2nd
Logo for Agendia
Agendia
2003, Irvine (United States), Series F
Provider of genomic diagnostic products for the treatment of cancer
$123M
61/100
3rd
Logo for Inflammatix
Inflammatix
2016, San Francisco (United States), Series E
Provider of diagnostic solutions for systemic infections
$191M
60/100
4th
Logo for InDevR
InDevR
2003, Boulder (United States), Acquired
Manufacturer of biotherapeutics, vaccines and diagnostic products
$16M
54/100
5th
Logo for KromaTiD
KromaTiD
2007, Fort Collins (United States), Series C
Provider of molecular and genetic tests for detection of disease-causing mutations
$15.4M
52/100
6th
Logo for GenomeDx Biosciences
GenomeDx Biosciences
2008, San Diego (United States), Series C
Genomic tests for urologic cancers
$69.7M
50/100
7th
Logo for Geneticure
Geneticure
2012, Minnetonka (United States), Series A
Personalized hypertension treatment through DNA analysis for better medication selection
$2.12M
46/100
8th
Logo for Affymetrix
Affymetrix
1991, Santa Clara (United States), Acquired
Life science solutions provider: reagents, instruments, and services for scientific discovery
-
46/100
9th
Logo for PamGene
PamGene
1999, Virginia (United States), Series B
Provider of a microarray platform and gene expression profiling system for post-genomic applications
$17.9M
43/100
10th
Logo for Diagnostic Hybrids
Diagnostic Hybrids
1983, Athens (United States), Acquired
Developer of molecular diagnostics kits for infectious diseases
$10M
41/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on InDevR's competitors? Click here to see the top ones

InDevR's Investments and acquisitions

InDevR has made no investments or acquisitions yet.

Reports related to InDevR

Here is the latest report on InDevR's sector:

News related to InDevR

lockFilter this list
Media has covered InDevR for 1 event in last 1 year.
•
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about InDevR

Explore our recently published companies
  • Inphosoft - Singapore based, 2002 founded, Unfunded company
  • IMPLASER - Alfajarin based, 1999 founded, Funding Raised company
  • HubLink - San Diego based, 2022 founded, Funding Raised company
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford